Xap Therapeutics Limited

General information

Name:

Xap Therapeutics Ltd

Office Address:

Babraham Research Campus Maia Building (b270) CB22 3AT Cambridge

Number: 10613866

Incorporation date: 2017-02-10

End of financial year: 31 December

Category: Private Limited Company

Status: Active

Description

Data updated on:

Xap Therapeutics Limited with the registration number 10613866 has been competing in the field for 7 years. This particular Private Limited Company can be reached at Babraham Research Campus, Maia Building (b270), Cambridge and its post code is CB22 3AT. The company debuted under the name Rockend, however for the last 3 years has been on the market under the name Xap Therapeutics Limited. This company's principal business activity number is 64303 and their NACE code stands for Activities of venture and development capital companies. The most recent accounts cover the period up to 2022-12-31 and the latest annual confirmation statement was filed on 2023-02-09.

The following company owes its success and permanent progress to exactly four directors, specifically Rodger N., Simeon G., Matthew F. and Shaun F., who have been managing the firm since April 2020. Moreover, the managing director's efforts are supported by a secretary - Josephine S., who was selected by the following company on 2022-07-19.

  • Previous company's names
  • Xap Therapeutics Limited 2021-07-20
  • Rockend Limited 2017-02-10

Financial data based on annual reports

Company staff

Josephine S.

Role: Secretary

Appointed: 19 July 2022

Latest update: 11 March 2024

Rodger N.

Role: Director

Appointed: 27 April 2020

Latest update: 11 March 2024

Simeon G.

Role: Director

Appointed: 05 September 2017

Latest update: 11 March 2024

Matthew F.

Role: Director

Appointed: 05 September 2017

Latest update: 11 March 2024

Shaun F.

Role: Director

Appointed: 10 February 2017

Latest update: 11 March 2024

People with significant control

Shaun F.
Notified on 10 February 2017
Ceased on 19 April 2021
Nature of control:
1/2 or less of shares
Rodger N.
Notified on 28 April 2020
Ceased on 19 April 2021
Nature of control:
1/2 or less of shares
Glaxosmithkline Finance Plc
Address: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
Legal authority United Kingdom (England And Wales)
Legal form Public Limited Company
Country registered England And Wales
Place registered Companies House
Registration number 00242686
Notified on 29 July 2020
Ceased on 17 September 2020
Nature of control:
1/2 or less of voting rights
1/2 or less of shares

Accounts Documents

Account next due date 30 September 2024
Account last made up date 31 December 2022
Confirmation statement next due date 23 February 2024
Confirmation statement last made up date 09 February 2023
Annual Accounts
Start Date For Period Covered By Report 10 February 2017
End Date For Period Covered By Report 28 February 2018
Annual Accounts
Start Date For Period Covered By Report 01 March 2018
End Date For Period Covered By Report 28 February 2019
Annual Accounts
Start Date For Period Covered By Report 01 March 2019
End Date For Period Covered By Report 31 December 2019

Company filings

Filing category

Hide filing type
Accounts Address Capital Confirmation statement Incorporation Mortgage Officers Persons with significant control Resolution
Free Download
Statement of Capital on 7th January 2024: 63.05 GBP (SH01)
filed on: 28th, January 2024
capital
Free Download Download filing (4 pages)

Search other companies

Services (by SIC Code)

  • 64303 : Activities of venture and development capital companies
7
Company Age

Closest Companies - by postcode